Business Description
![HOOKIPA Pharma Inc HOOKIPA Pharma Inc logo](https://static.gurufocus.com/logos/0C0000BLXK.png?14)
HOOKIPA Pharma Inc
NAICS : 325412
SIC : 2834
ISIN : US43906K1007
Description
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 15.25 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.14 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -2.45 | |||||
Beneish M-Score | 0.61 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -34.3 | |||||
3-Year EBITDA Growth Rate | 18.4 | |||||
3-Year EPS without NRI Growth Rate | 24.5 | |||||
3-Year FCF Growth Rate | 25.9 | |||||
3-Year Book Growth Rate | -44.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 22.14 | |||||
9-Day RSI | 25.96 | |||||
14-Day RSI | 31.35 | |||||
6-1 Month Momentum % | 8.43 | |||||
12-1 Month Momentum % | -7.15 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.5 | |||||
Quick Ratio | 4.5 | |||||
Cash Ratio | 3.14 | |||||
Days Sales Outstanding | 16.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.2 | |||||
Shareholder Yield % | -85.67 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -72.5 | |||||
Net Margin % | -88.73 | |||||
FCF Margin % | -154.68 | |||||
ROE % | -48.96 | |||||
ROA % | -28.78 | |||||
ROIC % | -98.59 | |||||
ROC (Joel Greenblatt) % | -257 | |||||
ROCE % | -37.85 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.25 | |||||
PB Ratio | 0.54 | |||||
Price-to-Tangible-Book | 0.54 | |||||
EV-to-EBIT | 0.65 | |||||
EV-to-EBITDA | 0.7 | |||||
EV-to-Revenue | -0.57 | |||||
EV-to-Forward-Revenue | 0.33 | |||||
EV-to-FCF | 0.37 | |||||
Price-to-Net-Current-Asset-Value | 0.61 | |||||
Price-to-Net-Cash | 1.09 | |||||
Earnings Yield (Greenblatt) % | 153.85 | |||||
FCF Yield % | -148.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:HOOK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HOOKIPA Pharma Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 53.552 | ||
EPS (TTM) ($) | -0.5 | ||
Beta | 0.56 | ||
Volatility % | 85.12 | ||
14-Day RSI | 31.35 | ||
14-Day ATR ($) | 0.054975 | ||
20-Day SMA ($) | 0.688705 | ||
12-1 Month Momentum % | -7.15 | ||
52-Week Range ($) | 0.41 - 1.13 | ||
Shares Outstanding (Mil) | 98.95 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
HOOKIPA Pharma Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
HOOKIPA Pharma Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
HOOKIPA Pharma Inc Frequently Asked Questions
What is HOOKIPA Pharma Inc(HOOK)'s stock price today?
The current price of HOOK is $0.56. The 52 week high of HOOK is $1.13 and 52 week low is $0.41.
When is next earnings date of HOOKIPA Pharma Inc(HOOK)?
The next earnings date of HOOKIPA Pharma Inc(HOOK) is 2024-08-09 Est..
Does HOOKIPA Pharma Inc(HOOK) pay dividends? If so, how much?
HOOKIPA Pharma Inc(HOOK) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |